Hyperthermia (HT) can act as a radiosensitizer by

  • increasing tumour perfusion and oxygenation
  • inhibitiing DNA repair
  • increasing immunological effects.

While different temperatures are optimal for these mechanisms, the whole temperature range of 39-43°C has been described as effective in combined hyperthermia/radiotherapy (HT/RT).

In order to achieve the most beneficial effects, the time gap between hyperthermia and radiotherapy treatment should be as short as possible.

The combination with HT enables effective tumour control with

  • significantly reduced RT dosage and toxicity
  • option of safe re-irradiation even in cases where re-irradiation in therapeutic dosage alone is not an option or associated with the risk of severe side-effects.

Randomized clinical studies comparing the combined HT/RT against RT alone showed an especially high benefit for pre-irradiated patients.

Good thermometry is crucial for quality assurance of HT treatments. Superficial temperatures can be measured by contact sensors and (in case of hydrosun®-TWH1500) by thermography. Invasive thermometry by intra-tumoral temperature sensors is restricted to punctual measurements, and the high heterogenity of tumours has to be taken into account.

Some of the described synergistic effects of HT can also work in combination with chemotherapy.


 

Print Email


heckel medizintechnik GmbH

Olgastrasse 25
73728 Esslingen

Tel: ++49 (0)711 - 128989 - 0
Fax: ++49 (0)711 - 128989 - 20

info@heckel-medizintechnik.de

 

Visit us on Facebook
 

Visit us on Linkedin

 

PARTNER OF

hydrosun

>

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.